🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

68+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 68 recruiting trials for “localized-scleroderma

Enrolling by InvitationNCT06472362

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

👨‍⚕️ Elisabetta A Renzoni, Royal Brompton and Harefield Hospitals📍 7 sites📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06655896

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 80 sites📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT06658483

Hand ScleroDerma Lived Experience Scale in Individuals With Systemic Sclerosis

🏥 Pamukkale University📍 2 sites📅 Started Oct 2024View details ↗
NARecruitingNCT06182293

Periodontal Microbiota in Systemic Sclerosis

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06470048

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 127 sites📅 Started Oct 2024View details ↗
Phase 1RecruitingNCT06646913

TENS in Scleroderma

🏥 University of Michigan📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT05785065

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

👨‍⚕️ Sabrina Hoa, MD, Centre hospitalier de l'Université de Montréal (CHUM)📍 3 sites📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06328777

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

👨‍⚕️ Medical Director, Cabaletta Bio📍 10 sites📅 Started Jul 2024View details ↗
RecruitingNCT06598982

Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis

🏥 Selcuk University📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06474910

Connective Tissue Massage in Scleroderma

🏥 Firat University📍 1 site📅 Started Jun 2024View details ↗
Phase 1RecruitingNCT06414135

Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis

👨‍⚕️ Liangjing Lu, RenJi Hospital📍 1 site📅 Started Jun 2024View details ↗
Phase 4RecruitingNCT06546540

The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis

🏥 Peking University Third Hospital📍 1 site📅 Started Jun 2024View details ↗
RecruitingNCT07012655

Color Doppler Ultrasonography Evaluation of Abdominal and Peripheral Vasculopathy in Systemic Sclerosis Patients

👨‍⚕️ Sara Farrag, Lecturer, Assiut University📍 1 site📅 Started May 2024View details ↗
RecruitingNCT06133244

Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)

🏥 UMC Utrecht📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06195072

Platform Clinical Study for Conquering Scleroderma

👨‍⚕️ Kevin O'Shea, Scleroderma Research Foundation📍 34 sites📅 Started Apr 2024View details ↗
NARecruitingNCT05533034

Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung Disease

👨‍⚕️ Camille DASTE, MD, Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT05989763

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

👨‍⚕️ Zsuzsanna H McMahan, MD, MHS (M-PI), The University of Texas Health Science Center, Houston📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05149768

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

👨‍⚕️ Janet E Pope, PhD, University of Western Ontario, Division of Rheumatology, St. Joseph's Health Care, London, Ontario, Canada📍 1 site📅 Started Feb 2024View details ↗
RecruitingNCT06051773

Evaluation of Muscle Involvement in Systemic Sclerosis

🏥 Central Hospital, Nancy, France📍 1 site📅 Started Jan 2024View details ↗
Phase 3RecruitingNCT06936215

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

👨‍⚕️ Dr MD. Fahad Hossain, MBBS, MD, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh📍 1 site📅 Started Jan 2024View details ↗
← PreviousPage 2 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →